• Search results for Covishield
Image Title

Study finds that majority of Indians experience mild or no side effects post COVID-19 vax

According to the study, 70 per cent of Indians after taking the first dose of Covishield and 64 per cent with Covaxin experienced no or mild side effects

Published on 25th August 2021
Vaccine_RGGH_EPS

COVID-19: Andhra Pradesh government to vaccinate people in 18-45 age group by first week of October 

About 9 lakh doses of Covishield and Covaxin were kept ready before commencing vaccination for the 18-45 age group

Published on 24th August 2021
COVID-19-Vaccine-6-3

Mixing Covishield and Covaxin can yield better results against COVID, says ICMR's new study

The study was conducted on individuals in Uttar Pradesh who received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks

Published on 8th August 2021
Covishield_(1)

India pushes Italy to recognise CoWIN certificate for Covishield

Italy is not on the list of countries that have given a "green pass" to the Astra-Zeneca vaccine manufactured by the Serum Institute of India 

Published on 10th July 2021
Covishield

After Switzerland, Iceland and others, Netherlands becomes latest EU country to approve Covishield

People who have been fully vaccinated can be exempted from the EU entry ban unless they are travelling from a country that has been designated as a very high-risk area due to the presence of a variant

Published on 2nd July 2021
vaccine-5873170_1920

Delhi government sets up vaccine centre for people travelling abroad for studies, work

The centre has been set up at the Navyug School on Mandir Marg. Those who wish to avail of the facility will have to carry their passports and relevant travel documents

Published on 14th June 2021
COVID-19_Test_PTI_

Risk of COVID among fully vaccinated healthcare workers significantly lower compared to unvaccinated HCWs, finds study

The data of this study as shared by the researchers states that two doses of Covishield gave the said HCWs 65 per cent protection against infection, 77 per cent against hospitalisation

Published on 11th June 2021
covaxin-1603676480

Bharat Biotech to release results of Phase 3 trials of Covaxin in July

This comes amid a raging debate on a recent pre-print study which said that while both Covaxin and Covishield showed a good immune response, Covishield produced more antibodies than Covaxin

Published on 10th June 2021
sputnikV-reuters-new

Serum Institute seeks DCGI nod to examine and manufacture Sputnik V in India

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June

Published on 3rd June 2021
COVID-19-Vaccine-6-3

Indian government dismisses reports that Covaxin may hamper plans to travel abroad

Multiple reports had said that over 130 countries across the globe currently accept Serum Institute of India's Covishield vaccine to enter their country while Covaxin is accepted in only nine n

Published on 22nd May 2021
hansraj-college

DU's Hansraj College sets up RT-PCR test centre on campus, wishes to start a 100-bed health facility

The principal had also sought the setting up of a vaccination centre at the college for administering Covishield vaccine to university staffers

Published on 12th May 2021
covid-19-vaccine

COVID-19: Those between 18 and 44 in Bengaluru can get vaccinated at major hospitals, med colleges from May 10

The statement said that the government has already placed orders for two crore doses of Covishield and one crore of Covaxin to vaccinate the estimated 3.26 crore people in this age group

Published on 9th May 2021
covid_vaccine

JD Institute rolls out free COVID vaccination camp for employees above 18 years 

The employees received the Covishield vaccine, developed by the Oxford-AstraZeneca and manufactured by the Serum Institute of India

Published on 7th May 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Government asks Serum Institute, Bharat Biotech to lower the price of COVID-19 vaccines: Official sources

The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals

Published on 27th April 2021
vaccine

Serum prices COVID vaccine for Pvt hospitals at Rs 600/dose, for state govt at Rs 400/dose 

SII said the Covishield vaccine will be available to state governments for Rs 400 per dose and to private hospitals at Rs 600 per dose

Published on 21st April 2021

Search results 1 - 15 of 108